Neuland Laboratories Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Harsh Piplani
- Category: Market
CMP Rs 20,925.00 (9 Oct 2026). 52W range Rs 11,500.00 to Rs 24,225.00. PE 54.16. 2027 base Rs 25,110, bull Rs 26,156.
Quick Answer
The Neuland Laboratories share price forecast for 2027 centres on a conservative case of Rs 24,064, a base case of Rs 25,110 and a bull case of Rs 26,156, against a current price of Rs 20,925.00. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 20.0% upside from today’s price. The daily technical setup reads bearish.
Neuland Laboratories share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 20,925.00 on NSE as of 9 October 2026, 13.6% below its 52-week high of Rs 24,225.00, after the company reported net profit of Rs 364 crore for FY26.
This Neuland Laboratories stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.
Click Here – Get Free Investment Predictions
Neuland Laboratories Share Price Today and Key Data
The Neuland Laboratories share price today is Rs 20,925.00 on NSE, down 0.43% on the day. The market capitalisation stands at Rs 26,961 crore. Over the past year the price has risen 33.1% from Rs 15,717.00. Every Neuland Laboratories stock forecast figure below starts from this price.
| Metric | Value |
|---|---|
| Company | Neuland Laboratories (NEULANDLAB) |
| Current Price | Rs 20,925.00 |
| 52-Week High | Rs 24,225.00 (9 September 2026) |
| 52-Week Low | Rs 11,500.00 (23 March 2026) |
| Market Cap | Rs 26,961 crore |
| PE Ratio | 54.16 |
| Industry PE | 37.59 |
| PB Ratio | 14.39 |
| EPS (TTM) | Rs 387.98 |
| Return on Equity | 19.42% |
| Debt to Equity | 0.16 |
| Dividend Yield | 0.16% |
| Book Value per Share | Rs 1,460.31 |
What Is the Neuland Laboratories Share Price Prediction for 2027?
The Neuland Laboratories share price prediction for 2027 is a conservative case of Rs 24,064, a base case of Rs 25,110 and a bull case of Rs 26,156. Against Rs 20,925.00, these imply 15.0% upside, 20.0% upside and 25.0% upside. They are model scenarios built from reported EPS growth, not broker targets.
| Scenario | EPS Growth Basis | EPS Estimate | PE Multiple | Implied Value | Upside vs Current Price |
|---|---|---|---|---|---|
| Conservative Case | Lower of FY26 growth (39.9%) and 4-year CAGR (54.5%) (capped at 15%) | Rs 446.18 (+15.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 24,064 | +15.0% |
| Base Case | Average of the two (capped at 20%) | Rs 465.58 (+20.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 25,110 | +20.0% |
| Bull Case | Higher of the two (capped at 25%) | Rs 484.98 (+25.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 26,156 | +25.0% |
Each target takes today’s price of Rs 20,925.00 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. Together they form the Neuland Laboratories target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.
Neuland Laboratories Share Price Forecast: What Has to Go Right by 2027
Each Neuland Laboratories target price below depends on a specific EPS outcome, and the text states that outcome next to the number.
Conservative Case for the Neuland Laboratories Share Price Target: Rs 24,064
Reaching Rs 24,064 needs EPS to rise 15.0% to Rs 446.18 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 54.5%.
Base Case for the Neuland Laboratories Share Price Target: Rs 25,110
Reaching Rs 25,110 needs EPS to rise 20.0% to Rs 465.58, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 962.4% in Q1 FY27 is at or above that pace, which supports the target.
Bull Case for the Neuland Laboratories Share Price Target: Rs 26,156
Reaching Rs 26,156 needs EPS to rise 25.0% to Rs 484.98 with the PE multiple held at today’s level. That is above the 52-week high of Rs 24,225.00, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 22,324.08 (50-day SMA) would be the first technical confirmation.
Neuland Laboratories Financial Performance: Revenue, Profit and Margins
Neuland Laboratories earned net profit of Rs 364 crore on revenue of Rs 2,053.15 crore in FY26, with profit up 39.9% and revenue up 37.1% compared with FY25. Diluted EPS was Rs 283.71 against Rs 202.74 a year earlier, and that earnings base anchors the Neuland Laboratories share price forecast.
| Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| FY22 | 953.15 | 63.82 | 49.74 | 15.21% | 6.70% |
| FY23 | 1,200.95 | 163.52 | 127.45 | 23.64% | 13.62% |
| FY24 | 1,571.12 | 300.08 | 233.89 | 30.49% | 19.10% |
| FY25 | 1,497.35 | 260.11 | 202.74 | 23.77% | 17.37% |
| FY26 | 2,053.15 | 364.00 | 283.71 | 29.89% | 17.73% |
In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 650.07 crore against Rs 300.61 crore a year earlier (+116.3%), and the bottom line was a net profit of Rs 147.67 crore against a net profit of Rs 13.90 crore (+962.4%). Operating margin was 36.06% versus 14.46% in the year-ago quarter. Cash flow from operations was Rs 346.68 crore in FY26 against Rs 317.40 crore in FY25. Together these figures set the earnings base for the Neuland Laboratories share price prediction.
Check the Univest Screener for live Neuland Laboratories fundamentals
Is Neuland Laboratories Overvalued or Undervalued Right Now?
Neuland Laboratories trades at a PE of 54.16 against an industry PE of 37.59, which places the stock at a 44.1% premium to the industry average. The price-to-book ratio is 14.39 on a book value of Rs 1,460.31 per share. Return on equity of 19.42% means the company earns Rs 19.42 of profit for every Rs 100 of shareholder equity.
Debt to equity is 0.16, so borrowings equal about 16% of shareholder equity. The company declared a dividend of Rs 34.00 per share for FY26, a yield of 0.16% at the current price. This valuation context frames the Neuland Laboratories stock price prediction for 2027 without relying on any outside forecast.
Neuland Laboratories Stock Analysis: Technical Outlook
Neuland Laboratories stock trades below its 50-day SMA of Rs 22,324.08 and above its 200-day EMA of Rs 18,370.05, and the combined daily indicators read bearish. The 52-week high of Rs 24,225.00 was set on 9 September 2026, while the 52-week low of Rs 11,500.00 came on 23 March 2026.
| Indicator | Reading | Signal |
|---|---|---|
| RSI (14) | 18.38 | Oversold |
| MACD (12,26,9) | -334.63 vs signal -188.85 | Bearish |
| ADX (14) | 54.24 | Established trend |
| Supertrend (10,3) | Price below Rs 23,198.00 | Bearish |
| 50-day SMA | Rs 22,324.08 | Price below |
| 200-day EMA | Rs 18,370.05 | Price above |
The nearest support level sits at Rs 18,370.05 (200-day EMA) and Rs 11,500.00 (52-week low). The nearest resistance level sits at Rs 22,324.08 (50-day SMA) and Rs 23,198.00 (Supertrend). A sustained move above the nearest resistance would support the Neuland Laboratories share price prediction 2027 base case, and this Neuland Laboratories stock analysis uses daily candles only. Chart signals add context to the Neuland Laboratories share price target without changing the earnings maths.
Neuland Laboratories Shareholding Pattern
Promoters hold 32.62% of Neuland Laboratories as of Jun 2026, down from 32.68% in Jun 2025 across the last 5 quarters. FII holding is 21.08% (down from 21.69% in Jun 2025) and DII holding is 16.51% (up from 11.57% in Jun 2025), which puts combined institutional holding at 37.59%. Public shareholders own 29.79%. Shareholding data is one input for any Neuland Laboratories stock forecast.
Key Risks to the Neuland Laboratories Share Price Target for 2027
Earnings and Margin Risk
Operating margin has ranged from 15.21% to 30.49% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Neuland Laboratories stock forecast. Revenue was up 37.1% in FY26, and slower revenue growth would weigh on the profit path.
Valuation Risk
The PE of 54.16 is 44.1% above the industry PE of 37.59. Every target here holds the multiple constant, so a narrowing of that premium would leave returns below these targets even if earnings grow as assumed.
Size and Liquidity Risk
Market capitalisation stands at Rs 26,961 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Neuland Laboratories stock price target.
Balance Sheet Risk
Debt to equity of 0.16 means borrowings stand at about 16% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Neuland Laboratories share price forecast.
Technical Risk
The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 18,370.05 (200-day EMA) would weaken the setup further.
Conclusion
This Neuland Laboratories stock analysis puts the share price target range for 2027 at Rs 24,064 to Rs 26,156, with a base case of Rs 25,110 against Rs 20,925.00 today. The inputs are a PE of 54.16 that sits at a 44.1% premium to the industry average, EPS growth of 39.9% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.
Download the Univest iOS App or Univest Android App to track Neuland Laboratories live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Neuland Laboratories Share Price Prediction 2027
What is the Neuland Laboratories share price target for 2027?
Ans. The Neuland Laboratories share price forecast for 2027 has a conservative case of Rs 24,064, a base case of Rs 25,110 and a bull case of Rs 26,156. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.
What is the Neuland Laboratories share price today?
Ans. Neuland Laboratories trades at Rs 20,925.00 on NSE as of 9 October 2026, down 0.43% on the day. The 52-week range is Rs 11,500.00 to Rs 24,225.00.
Is Neuland Laboratories a good stock to buy for 2027?
Ans. The data points in different directions: the PE of 54.16 is at a 44.1% premium to the industry average, EPS grew 39.9% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.
Can Neuland Laboratories stock reach Rs 26,156 in 2027?
Ans. Reaching Rs 26,156 needs EPS to rise 25.0% from Rs 387.98 with the PE multiple held at today’s level, plus a daily close above Rs 22,324.08 (50-day SMA). This is a scenario, not a guarantee.
What are the support and resistance levels for Neuland Laboratories?
Ans. The nearest support levels are Rs 18,370.05 (200-day EMA) and Rs 11,500.00 (52-week low), and the nearest resistance levels are Rs 22,324.08 (50-day SMA) and Rs 23,198.00 (Supertrend).
What are the main risks for Neuland Laboratories stock in 2027?
Ans. The main risks to the Neuland Laboratories share price forecast are a fall in operating margin from the 15.21% to 30.49% range seen since FY22, slower revenue growth after FY26 revenue was up 37.1%, and thin trading volumes. Debt to equity of 0.16 adds balance sheet sensitivity.
How is the Neuland Laboratories target price for 2027 calculated?
Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company’s reported FY26 and 4-year EPS growth.
